Editorial

A Very “Relevant” PCA 2021 Recap

Less than three weeks since we published our first booth post of the 2021 PCA Convention & Trade Show, we are finally ready to close…

Five Things: What Today’s Federal Appeals Court Loss Means for Cigars

Today, the cigar industry suffered a resounding defeat at the U.S. Court of Appeals for the District of Columbia. It’s the latest ruling in Cigar…

Córdoba & Morales Karole Bashkins

Check your calendar, because it is once again that time on halfwheel. On April Fools’ Day, we attempt to give a serious review to what could…

The Week That Never Ends (Programming Notes)

This annual New Year’s tradition at halfwheel contains a few elements. There’s the programming notes portion, a reminder, a reflection and a small peak into what…

Ten Questions for 2021

There are less than a dozen hours of the year—the year—remaining. As I’ve done at this point of each year for over a decade, it’s…

Graded: Ten Questions for 2020

The idea of the words graded and 2020 bring a bit of a smirk and sigh to my face. Certainly conventional wisdom—and an endless stream of social…

What the Election Results Mean for Cigar Smokers: 2020 Edition

Barring some very on-brand 2020 curveballs, Joe Biden will be the next president of the United States. As I did the last time I published…

10 Thoughts: FDA’s Substantial Equivalence Requirements Delayed for Premium Cigars

Yesterday, the U.S. District Court for the District of Columbia ruled that the U.S. Food & Drug Administration’s premarket approval deadline of Sept. 9, 2020…

12 Thoughts: FDA Wants to Reevaluate How to Regulate Premium Cigars

By Sept. 8, 2020 cigar manufacturers and others will have to submit documentation to the U.S. Food & Drug Administration (FDA) for premarket approval to…

Six Thoughts: Goodbye to Nat Sherman

When I was growing up, my father’s humidor was a Nat Sherman humidor. The small thing that he bought in the 1980s could probably store…

Six Thoughts: Appeals Court Strikes Down All FDA Cigar & Pipe Warning Labels

Earlier today, the U.S. Court of Appeals for the District of Columbia Circuit ruled that the U.S. Food & Drug Administration (FDA) could not require…